Answers are grounded in this paper and cite their sources.
Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.
No takes yet. Share an insight, caveat, or question.
Caroline Robert (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: